Technical Analysis for GBIM - Globeimmune Cm

Grade Last Price % Change Price Change
grade D 0.0995 24.38% 0.0195
GBIM closed up 24.38 percent on Wednesday, August 21, 2019, on 1.94 times normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical GBIM trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Spinning Top Other 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 24.38%
Narrow Range Bar Range Contraction 24.38%
Inside Day Range Contraction 24.38%

Older signals for GBIM ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
GlobeImmune, Inc. is a biopharmaceutical company. The Company is focused on developing products for the treatment of cancer and infectious diseases based on its Tarmogen platform. The Company's segment is the business of developing and commercializing various biopharmaceutical products. The Company's infectious disease product candidates include GS-4774, which is in Phase II for the treatment of chronic hepatitis B infection; GI-19000; GI-2010, which is in the preclinical stage of development for the treatment of Human immunodeficiency virus (HIV), and GI-18000, which is in the preclinical stage of development for the treatment of Chronic hepatitis D infection. The Company's oncology product candidates include GI-6207, which is in Phase II for the treatment of medullary thyroid cancer; GI-6301, and GI-4000, which is in Phase IIb for the treatment of Resected pancreas cancer, and in Phase II for the treatment of Non-small cell lung cancer and colorectal cancer.
Medicine RTT Medical Specialties Cancer Biopharmaceutical Infectious Diseases Treatment Of Cancer Hiv Colorectal Cancer Hepatitis Biopharmaceutical Products Infectious Disease Non Small Cell Lung Cancer Infectious Causes Of Cancer Treatment Of Non Small Cell Lung Cancer
Is GBIM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicator Value
52 Week High 0.6
52 Week Low 0.0351
Average Volume 14,802
200-Day Moving Average 0.2421
50-Day Moving Average 0.1031
20-Day Moving Average 0.0975
10-Day Moving Average 0.0882
Average True Range 0.0264
ADX 13.76
+DI 27.5319
-DI 32.9623
Chandelier Exit (Long, 3 ATRs ) 0.0597
Chandelier Exit (Short, 3 ATRs ) 0.1397
Upper Bollinger Band 0.1368
Lower Bollinger Band 0.0582
Percent B (%b) 0.53
BandWidth 80.615385
MACD Line -0.0056
MACD Signal Line -0.0046
MACD Histogram -0.001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1309
Resistance 3 (R3) 0.1297 0.1180 0.1256
Resistance 2 (R2) 0.1180 0.1100 0.1186 0.1239
Resistance 1 (R1) 0.1088 0.1051 0.1134 0.1100 0.1221
Pivot Point 0.0971 0.0971 0.0995 0.0977 0.0971
Support 1 (S1) 0.0879 0.0891 0.0925 0.0891 0.0769
Support 2 (S2) 0.0762 0.0842 0.0768 0.0751
Support 3 (S3) 0.0670 0.0762 0.0734
Support 4 (S4) 0.0682